Literature DB >> 29666800

Strategies of nodal staging of the TNM system for esophageal cancer.

Wen-Ping Wang1, Song-Lin He1, Yu-Shang Yang1, Long-Qi Chen1.   

Abstract

The 8th edition of UICC/AJCC TNM staging for esophageal cancer will start in use since 2018. The nodal staging in this version of TNM system remains unchanged from the 7th edition that based on the number of lymph nodes (LN) involved, except the limited revision of the regional LN map. In this review, N staging revision was evaluated from its initially simple definition of negative (N0) and positive (N1) LN(s) to the current positive node number based proposal. Meanwhile the disadvantages of current N staging were discussed. The refined nodal staging system in view of the number of metastatic node stations was introduced; as well as the extent and station of metastatic node could better reflect the disease progression and prognosis. The controversy on N staging of esophagogastric junction cancer was also discussed. Other reported N staging associated elements including LN ratio and lymphatic vessel invasion were reviewed and evaluated.

Entities:  

Keywords:  Esophageal cancer; N staging; TNM staging; metastasis of lymph node (LN)

Year:  2018        PMID: 29666800      PMCID: PMC5890030          DOI: 10.21037/atm.2017.12.17

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  39 in total

1.  Prognostic relevance of skip metastases in esophageal cancer.

Authors:  Klaus L Prenzel; Elfriede Bollschweiler; Wolfgang Schröder; Stefan P Mönig; Uta Drebber; Daniel Vallboehmer; Arnulf H Hölscher
Journal:  Ann Thorac Surg       Date:  2010-11       Impact factor: 4.330

2.  Lymph node ratio: a confounded quotient.

Authors:  Thomas W Rice; Eugene H Blackstone
Journal:  Ann Thorac Surg       Date:  2013-08       Impact factor: 4.330

3.  Lymph node station ratio: Revised nodal category for resected esophageal squamous cell carcinoma patients.

Authors:  Xiayu Fu; Qianwen Liu; Kongjia Luo; Jing Wen; Hong Yang; Yi Hu; Xinye Wang; Peng Lin; Jianhua Fu
Journal:  J Surg Oncol       Date:  2017-07-13       Impact factor: 3.454

4.  The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.

Authors:  Jessica M Leers; Steven R DeMeester; Arzu Oezcelik; Nancy Klipfel; Shahin Ayazi; Emmanuele Abate; Jörg Zehetner; John C Lipham; Linda Chan; Jeffrey A Hagen; Tom R DeMeester
Journal:  Ann Surg       Date:  2011-02       Impact factor: 12.969

5.  The N-classification for esophageal cancer staging: should it be based on number, distance, or extent of the lymph node metastasis?

Authors:  Qi-Rong Xu; Xue-Peng Zhuge; He-Lin Zhang; Yu-Min Ping; Long-Qi Chen
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

6.  Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.

Authors:  Mohamad A Eloubeidi; Renee Desmond; Miguel R Arguedas; Carolyn E Reed; C Mel Wilcox
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

7.  Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.

Authors:  Jessica M Leers; Steven R DeMeester; Nadia Chan; Shahin Ayazi; Arzu Oezcelik; Emmanuele Abate; Farzaneh Banki; John C Lipham; Jeffrey A Hagen; Tom R DeMeester
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07-14       Impact factor: 5.209

8.  Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.

Authors:  Corrado Pedrazzani; Giovanni de Manzoni; Daniele Marrelli; Simone Giacopuzzi; Giovanni Corso; Anna Maria Minicozzi; Bernardino Rampone; Franco Roviello
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08       Impact factor: 5.209

9.  Optimum lymphadenectomy for esophageal cancer.

Authors:  Nabil P Rizk; Hemant Ishwaran; Thomas W Rice; Long-Qi Chen; Paul H Schipper; Kenneth A Kesler; Simon Law; Toni E M R Lerut; Carolyn E Reed; Jarmo A Salo; Walter J Scott; Wayne L Hofstetter; Thomas J Watson; Mark S Allen; Valerie W Rusch; Eugene H Blackstone
Journal:  Ann Surg       Date:  2010-01       Impact factor: 12.969

10.  Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer.

Authors:  Koen Talsma; Pieter van Hagen; Brechtje A Grotenhuis; Ewout W Steyerberg; Hugo W Tilanus; Jan J B van Lanschot; Bas P L Wijnhoven
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

View more
  6 in total

1.  Comparable Clinical Outcome Using Small or Large Gross Tumor Volume-to-Clinical Target Volume Margin Expansion in Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma.

Authors:  Tae Hoon Lee; Hak Jae Kim; Byoung Hyuck Kim; Chang Hyun Kang; Bhumsuk Keam; Hyeon Jong Moon; Yong Won Seong; Suzy Kim
Journal:  J Oncol       Date:  2022-06-03       Impact factor: 4.501

2.  Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma.

Authors:  Lucia Suzuki; Fiebo J C Ten Kate; Annieke W Gotink; Hans Stoop; Michail Doukas; Daan Nieboer; Manon C W Spaander; Jan J B van Lanschot; Bas P L van Wijnhoven; Arjun D Koch; Marco J Bruno; Leendert H J Looijenga; Katharina Biermann
Journal:  PLoS One       Date:  2019-07-08       Impact factor: 3.240

3.  Development and validation of nomograms to intraoperatively predict metastatic patterns in regional lymph nodes in patients diagnosed with esophageal cancer.

Authors:  Fei Zhao; Rong-Xin Lu; Jin-Yuan Liu; Jun Fan; Hao-Ran Lin; Xiao-Yu Yang; Shu-Hui You; Qian-Ge Wu; Xue-Yun Qin; Yi Liu; Fu-Xi Zhen; Jin-Hua Luo; Wei Wang
Journal:  BMC Cancer       Date:  2021-01-05       Impact factor: 4.430

4.  Long-term outcomes and prognostic factor analysis of resected Siewert type II adenocarcinoma of esophagogastric junction in China: a seven-year study.

Authors:  Yiding Feng; Youhua Jiang; Qiang Zhao; Jinshi Liu; Hangyu Zhang; Qixun Chen
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102

5.  Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.

Authors:  He-San Luo; Ying-Ying Chen; Wei-Zhen Huang; Sheng-Xi Wu; Shao-Fu Huang; Hong-Yao Xu; Ren-Liang Xue; Ze-Sen Du; Xu-Yuan Li; Lian-Xin Lin; He-Cheng Huang
Journal:  Radiat Oncol       Date:  2021-10-12       Impact factor: 3.481

6.  A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.

Authors:  He-San Luo; Shao-Fu Huang; Hong-Yao Xu; Xu-Yuan Li; Sheng-Xi Wu; De-Hua Wu
Journal:  Radiat Oncol       Date:  2020-10-29       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.